SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-19-001727
Filing Date
2019-03-14
Accepted
2019-03-14 16:10:28
Documents
78
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031219p.htm 10-K 1105844
2 EXHIBIT 21 exh_21.htm EX-21 1924
3 EXHIBIT 23 exh_23.htm EX-23 4520
4 EXHIBIT 31.1 exh_311.htm EX-31.1 6803
5 EXHIBIT 31.2 exh_312.htm EX-31.2 6817
6 EXHIBIT 32.1 exh_321.htm EX-32.1 4007
7 EXHIBIT 32.2 exh_322.htm EX-32.2 4082
14 GRAPHIC graph.jpg GRAPHIC 28849
  Complete submission text file 0001171843-19-001727.txt   6575803

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE bcrx-20181231.xml EX-101.INS 1267354
9 XBRL SCHEMA FILE bcrx-20181231.xsd EX-101.SCH 74258
10 XBRL CALCULATION FILE bcrx-20181231_cal.xml EX-101.CAL 56067
11 XBRL DEFINITION FILE bcrx-20181231_def.xml EX-101.DEF 533174
12 XBRL LABEL FILE bcrx-20181231_lab.xml EX-101.LAB 462448
13 XBRL PRESENTATION FILE bcrx-20181231_pre.xml EX-101.PRE 556629
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 19681163
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1